Summary
Existing methods of detecting adverse drug reactions are reviewed and an information system whereby the total number of patients exposed to a drug and the total number of patients developing an adverse reaction can be ascertained is described. Its potential as a monitoring system was tested by investigating, in 204 patients identified as receiving α-methyldopa, the known association of haemolytic anaemia with that drug. — Patients remaining on α-methyldopa were repeatedly screened and in this series one patient had developed haemolytic anaemia and 10 patients had antibodies to α-methyldopa as evidenced by a positive direct antiglobulin test. Follow-up effectively determined the frequency of haemolytic anaemia which appeared to be a relatively small hazard and should not prejudice the use of the drug. This study has highlighted the difficulties in the adequate assessment of hypertension prior to commencing treatment and has shown that drug monitoring for adverse reactions may have an important role in the establishment of criteria for the more effective use of drugs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Carstairs, K.C., Breckenridge, A., Dollery, C.T., Worlledge, S.M.: Incidence of a positive direct Coombs test in patients on α-methyldopa. Lancet1966 II, 133–135.
Cluff, L.E., Thornton, G.F., Seidl, L.G.: Studies on the epidemiology of adverse drug reactions. J. Amer. med. Ass.188, 976–983 (1964).
Coull, D.C., Crooks, J., Dingwall-Fordyce, I., Scott, A.M., Weir, R.D.: A method of monitoring drugs for adverse reactions II. Amitriptyline and cardiac disease. Europ. J. clin. Pharmacol.3, 51–55 (1970).
Coull, D.C., Marron, A.C., Crooks, J., Weir, R.D.: Drug monitoring in the health services. Health bulletin, Scottish Home and Health Department26, 38–40 (1968).
Croft, J.D., Swisher, S.N., Gilliland, B.C., Bakemeier, R.F., Leddy, J.P., Weed, R.I.: Coombs'-test positivity induced by drugs. Mechanisms of immunologic reactions and red cell destruction. Ann. int. Med.68, 176–187 (1968).
Crooks, J., Clark, C.G., Caie, H.B., Mawson, W.B.: Prescribing and administration of drugs in hospital. Lancet1965 I, 373–378.
Crooks, J., Weir, R.D., Coull, D.C., McNab, J.W., Calder, G., Barnett, J.W., Caie, H.B.: Evaluation of a method of prescribing drugs in hospital, and a new method of recording their administration. Lancet1967 I, 668–671.
Hamilton, M.: Some aspects of the long-term treatment of severe hypertension with methyldopa. Post-grad. med. J.44, 66–69 (1968).
Hedley, A.J., Scott, A.M., Debenham, G.: A computer assisted follow-up register. Methods of Information in Medicine8, 67–77 (1969).
Hodge, J.V., Casey, T.P.: Methyldopa and the direct antiglobulin (Coombs') test. N.Z. med. J.68, 240–246 (1968).
Hurwitz, N., Wade, O.L.: Intensive hospital monitoring of adverse reactions to drugs. Brit. med. J.1969 I, 531–536.
Vessey, M.P., Doll, R.: Investigation of relation between use of oral contraceptives and thromboembolic disease. Brit. med. J.1968 II, 199–205.
Weiner, W.: “Coombs Positive” “Normal” People. Proc. 10th Congr. int. Soc. Blood Transf., Stockholm 1964; 35–39 (1965).
World Health Organisation: Meeting on the role of the hospital in international drug monitoring. World Health Organisation Technical Report Series 425, 1–24 (1969).
Worlledge, S.M.: Immune drug-induced haemolytic anaemia. Seminars in Haematology6, 181–200 (1969).
Carstairs, K.C., Dacie, J.V.: Autoimmune haemolytic anaemia associated with α-methyldopa therapy. Lancet1966 II, 135–139.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Coull, D.C., Crooks, J., Davidson, J.F. et al. A method of monitoring drugs for adverse reactions I. α-methyldopa and haemolytic anaemia. Eur J Clin Pharmacol 3, 46–50 (1970). https://doi.org/10.1007/BF00560291
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00560291